EUVIMEDEUVIMED entdecken
Crossref

Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus

Sophie Hartuis iD, Manon Robert iD, Taieb Chouaki iD, Florent Morio iD, Carlos Arturo Alvarez-Moreno iD, Patrice Le Pape iD, Rose-Anne Lavergne iD

Medical Mycology · 2025

DOI: 10.1093/mmy/myaf110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Sophie Hartuis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CHU Nantes, Cibles et médicaments des infections et de l'immunité, IICiMed, UR 1155, F-44000 Nantes, France. Hauptthemen laut MEDLINE: Aspergillus fumigatus, Antifungal Agents, Aspergillosis, Fungicides, Industrial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspergillus fumigatus is a human pathogen and a ubiquitous environmental mould. Consequently, A. fumigatus may be exposed to agricultural fungicides widely used for crop protection. The use of azole fungicides in the environment has been implicated in the emergence of azole antifungal resistance in A. fumigatus. In vitro susceptibility of a collection of both clinical (n = 14) and environmental (n = 6) A. fumigatus isolates was determined against fungicides with different modes of action (demethylation inhibitors, Succinate DeHydrogenase Inhibitor (SDHI), Quinone outside Inhibitors (QoI), Methyl Benzimidazole Carbamate (MBC) and polyene). Sequencing of tubA, CYTB and SDHB, which encode the cellular targets of these fungicides, was performed. Eventually, the impact of resistance on the basal growth kinetics was assessed using a selection of two susceptible and two resistant isolates. Cross-resistance between medical triazole antifungal and agricultural triazole fungicides was confirmed, except for isolates with G54R/E substitutions in the cyp51A protein. No correlation was observed between resistance to triazole antifungals and imidazole fungicides. We identified seven MBC- (five environmental and two clinical isolates), five QoI- (three environmental and two clinical isolates) and one environmental SDHI-resistant isolates. Resistant phenotypes were associated with amino acid substitutions in beta-tubulin (F219Y and E217A), cytB (G143A) and sdhB (H270Y). Multi-fungicide resistance was not systematically associated with reduced growth kinetic. Multi-fungicide resistance, including at least resistance to one non-azole fungicide, was identified in sevenA. fumigatus isolates, of which two were clinical isolates. This last observation supports the hypothesis of the environmental pathway leading to antifungal resistance in A. fumigatus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillus fumigatusAntifungal AgentsAspergillosisFungicides, IndustrialDrug Resistance, Multiple, FungalEnvironmental MicrobiologyDrug Resistance, FungalHumansMicrobial Sensitivity TestsFungal ProteinsSequence Analysis, DNATubulin

Stichwörter der Autor:innen

Aspergillus fumigatusagricultural fungicidesenvironmentmedical azolemulti-resistance

Substanzen

Antifungal AgentsFungicides, IndustrialFungal ProteinsTubulin

Autor:innen und Institutionen

  • Nantes Université, CHU Nantes, Cibles et médicaments des infections et de l'immunité, IICiMed, UR 1155, F-44000 Nantes, France.
  • Service de Parasitologie Mycologie Médicales, CHU Amiens Picardie 80054 Amiens, France.
  • Inserm U1285, Univ. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
  • Universidad Nacional de Colombia, Facultad de Medicina, Departamento de Medicina Interna, Bogotá 111321, Colombia.
  • Clínica Universitaria Colombia, Clínica Colsanitas Grupo Keralty, Bogotá 110121, Colombia.

ORCID-Profile: Sophie Hartuis, Manon Robert, Taieb Chouaki, Florent Morio, Carlos Arturo Alvarez-Moreno, Patrice Le Pape, Rose-Anne Lavergne

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Hartuis, S., Robert, M., Chouaki, T., Morio, F., Alvarez-Moreno, C. A., Le Pape, P., & Lavergne, R. A. (2025). Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus. Medical Mycology. https://doi.org/10.1093/mmy/myaf110

Vancouver

Hartuis S, Robert M, Chouaki T, Morio F, Alvarez-Moreno CA, Le Pape P, et al. Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus. Medical Mycology. 2025. doi:10.1093/mmy/myaf110

BibTeX
@article{Hartuis2025,
  author = {Hartuis, Sophie and Robert, Manon and Chouaki, Taieb and Morio, Florent and Alvarez-Moreno, Carlos Arturo and Le Pape, Patrice and Lavergne, Rose-Anne},
  title = {Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus},
  journal = {Medical Mycology},
  year = {2025},
  doi = {10.1093/mmy/myaf110}
}
Kostenlos starten →